Stay updated with breaking news from Director Eric. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brown Shipley& Co Ltd trimmed its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 12.2% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biotechnology company’s stock after selling 102 shares during the period. Brown Shipley& Co Ltd’s holdings in Biogen […]
Brown Shipley& Co Ltd lowered its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 12.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 732 shares of the biotechnology company’s stock after selling 102 shares during the period. Brown […]
Advisors Capital Management LLC acquired a new position in Biogen Inc. (NASDAQ:BIIB – Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 1,071 shares of the biotechnology company’s stock, valued at approximately $275,000. Several other institutional investors and hedge funds have also made changes to their […]
Boone Capital Management LLC increased its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 52.9% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 96,115 shares of the biotechnology company’s stock after purchasing an additional 33,238 shares during the period. Biogen comprises about 7.8% of Boone […]
Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by Canaccord Genuity Group from $310.00 to $305.00 in a research note published on Tuesday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the biotechnology company’s stock. Several other research firms have also commented on BIIB. Robert W. Baird reduced their price […]